TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 8653869

Group type: EXPERIMENTAL
Intervention: Lovastatin and probucol
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Lovastatin and cholestyramine
Number of subjects: 23
Study: 1918553

Group type: EXPERIMENTAL
Intervention: Thermal biofeedback (TBF) treatment with regular home practice (group 1)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Thermal biofeedback (TBF) treatment without home practice (group 2)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Monitoring headaches (control group 3)
Number of subjects: 69
Study: 6863881

Group type: EXPERIMENTAL
Intervention: Boots secretin
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Synthetic secretin
Number of subjects: 9

Group type: COMPARATOR
Intervention: Control subjects (no specific intervention)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Synthetic CCK 8
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Normal saline (used as diluent)
Number of subjects: 9
Study: 29730456

Group type: EXPERIMENTAL
Intervention: 3D printing
Number of subjects: 20

Group type: COMPARATOR
Intervention: Freehand technique
Number of subjects: 20
Study: 29533028

Group type: EXPERIMENTAL
Intervention: Cytoreductive surgery + HIPEC
Number of subjects: 56

Group type: COMPARATOR
Intervention: Cytoreductive surgery alone
Number of subjects: 56
Study: 27011257

Group type: EXPERIMENTAL
Intervention: Fruit and nuts dietary pattern
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Seafood dietary pattern
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Yeast extract and seasonings dietary pattern
Number of subjects: 118
Study: 26338739

Group type: EXPERIMENTAL
Intervention: Isotretinoin 0.5 mg/kg/day
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Isotretinoin 1.0 mg/kg/day
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control group (healthy individuals)
Number of subjects: 62
Study: 23110500

Group type: EXPERIMENTAL
Intervention: Diethylstilbestrol (DES) 1-3 mg daily with 75 mg aspirin
Number of subjects: 231
Study: 20576472

Group type: COMPARATOR
Intervention: Intrauterine balloon only (group 1)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Fresh amnion graft (group 2)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Dried amnion graft (group 3)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Amnion graft (fresh vs dried)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Amnion graft (overall)
Number of subjects: 45
Study: 18837197

Group type: EXPERIMENTAL
Intervention: Electrical Twitch‐Obtaining Intramuscular Stimulation (eToims) using ET127 system, 3 Hz, 4 stimuli/site
Number of subjects: 92

Group type: COMPARATOR
Intervention: Basic Group (BG) stimulation, 1 Hz, 1 stimulus/site
Number of subjects: 92
Study: 16247790

Group type: EXPERIMENTAL
Intervention: CHOP with 80 mg/day of valsartan
Number of subjects: 40

Group type: COMPARATOR
Intervention: CHOP without valsartan (control)
Number of subjects: 40
Study: 12110072

Group type: EXPERIMENTAL
Intervention: Low-intensity resistance exercise (LEX)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: High-intensity resistance exercise (HEX)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 62
Study: 10533775

Group type: COMPARATOR
Intervention: Oesophagectomy alone (group A)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Neo-adjuvant chemoradiotherapy combined with oesophagectomy (group B)
Number of subjects: 74
Study: 7488771

Group type: EXPERIMENTAL
Intervention: Centrifugal pump (Biomedicus)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Roller pump (Stöckert)
Number of subjects: 26
Study: 1690068

Group type: EXPERIMENTAL
Intervention: Indoramin 20 mg bd
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Indoramin 20 mg nocte
Number of subjects: 121

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 121
Study: 7084142

Group type: EXPERIMENTAL
Intervention: Diazepam solution 20 mg administered rectally
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 31977610

Group type: EXPERIMENTAL
Intervention: Smartphone data capture tool
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard voice-dictated operative notes
Number of subjects: 100
Study: 30789089

Group type: EXPERIMENTAL
Intervention: Unexpected objects associated with high reward value
Number of subjects: 537

Group type: EXPERIMENTAL
Intervention: Unexpected objects associated with low reward value
Number of subjects: 537

Group type: EXPERIMENTAL
Intervention: Unexpected objects associated with no reward value
Number of subjects: 537
Study: 28657182

Group type: EXPERIMENTAL
Intervention: Blonanserin
Number of subjects: 0
Study: 25592561

Group type: EXPERIMENTAL
Intervention: Intensified post-operative chemotherapy (SIOPWT2001)
Number of subjects: 238

Group type: COMPARATOR
Intervention: Historical control chemotherapy (SIOP93-01)
Number of subjects: 238

Group type: EXPERIMENTAL
Intervention: Intensified treatment in Stage I (SIOPWT2001)
Number of subjects: 238

Group type: COMPARATOR
Intervention: Historical control treatment in Stage I (SIOP93-01)
Number of subjects: 238
Study: 23803894

Group type: EXPERIMENTAL
Intervention: Disturbed sleep (2330-0730)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Nondisturbed sleep (control) (2330-0730)
Number of subjects: 15
Study: 21717719

Group type: EXPERIMENTAL
Intervention: First measurement of sensitivity
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Second measurement of sensitivity
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: First measurement of specificity
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Second measurement of specificity
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Inter-observer agreement (first measurement)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Inter-observer agreement (second measurement)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Combined BI-RADS categories agreement
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Intra-observer agreement
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Multivariate analysis on interpreted mammograms
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Multivariate analysis on courses taken
Number of subjects: 29
Study: 19318865

Group type: EXPERIMENTAL
Intervention: Open reduction and internal fixation (ORIF) using volar locking plate (n = 53)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Closed reduction and casting (CAST) (n = 61)
Number of subjects: 130
Study: 20071596

Group type: EXPERIMENTAL
Intervention: ATV 300 mg with ritonavir (RTV) 100 mg (ATV300/r, n = 95)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: ATV 400 mg (ATV400; n = 105)
Number of subjects: 200
Study: 15642080

Group type: EXPERIMENTAL
Intervention: Ezetimibe 10 mg/day added to simvastatin 20 mg/day
Number of subjects: 214

Group type: COMPARATOR
Intervention: Simvastatin 40 mg/day (doubling the dose of simvastatin)
Number of subjects: 214
Study: 12140204

Group type: EXPERIMENTAL
Intervention: Oral aldose reductase inhibitor (ONO-2235)
Number of subjects: 21
Study: 9973093

Group type: EXPERIMENTAL
Intervention: Screening (PSA measurement and DRE)
Number of subjects: 46193

Group type: COMPARATOR
Intervention: No screening (control group)
Number of subjects: 46193
Study: 7478692

Group type: EXPERIMENTAL
Intervention: Isometric contraction of m. quadriceps femoris
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Local anesthetic cream
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control cream
Number of subjects: 14
Study: 2137902

Group type: EXPERIMENTAL
Intervention: Ondansetron (GR 38032F)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Metoclopramide
Number of subjects: 97
Study: 7006442

Group type: EXPERIMENTAL
Intervention: ICI 35868 (Diprivan) 1-2 mg/kg
Number of subjects: 20

Group type: COMPARATOR
Intervention: Althesin 0.5 ml/kg
Number of subjects: 20
Study: 29716660

Group type: EXPERIMENTAL
Intervention: Blended psychosocial support program based on Acceptance and Commitment Therapy, consisting of 1 face-to-face contact, 6 online guided modules, and 1 telephone contact over 8 weeks.
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Blended psychosocial support program
Number of subjects: 140

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 140
Study: 27460267

Group type: EXPERIMENTAL
Intervention: Domestic household activities
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Actual METS (METSactual)
Number of subjects: 10
Study: 24415271

Group type: EXPERIMENTAL
Intervention: Zofenopril 30 mg plus HCTZ 12.5 mg
Number of subjects: 361

Group type: COMPARATOR
Intervention: Irbesartan 150 mg plus HCTZ 12.5 mg
Number of subjects: 361

Group type: EXPERIMENTAL
Intervention: Zofenopril + HCTZ
Number of subjects: 361

Group type: COMPARATOR
Intervention: Irbesartan + HCTZ
Number of subjects: 361
Study: 22764601

Group type: EXPERIMENTAL
Intervention: Acupuncture + bloodletting (Xingjian (LR 2), Taichong (LR 3), Zhongfeng (LR 4), Ququan (LR 5) and pricking Dadun (LR 1) for bloodletting)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Fluoxetine (20 mg/d, PO in the morning)
Number of subjects: 30
Study: 20484492

Group type: EXPERIMENTAL
Intervention: Text message regarding online registration facility
Number of subjects: 1121

Group type: EXPERIMENTAL
Intervention: Letter with £5 enclosed
Number of subjects: 1121

Group type: EXPERIMENTAL
Intervention: Text messages containing quotes from participants
Number of subjects: 1121

Group type: COMPARATOR
Intervention: Standard Txt2stop procedures
Number of subjects: 1121
Study: 18305954

Group type: EXPERIMENTAL
Intervention: Allicin supplementation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 0
Study: 15804294

Group type: EXPERIMENTAL
Intervention: Histamine concentrations (0.1, 1.0, and 10 mg/ml)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Physiologic saline (negative control)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 100‐mm visual analog scale and a four‐stepped verbal rating scale
Number of subjects: 60
Study: 12483236

Group type: COMPARATOR
Intervention: 0.2% CHX rinses
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: 40 mg CHX tablets
Number of subjects: 22

Group type: COMPARATOR
Intervention: 30 mg CHX tablets
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo tablets
Number of subjects: 22
Study: 10726236

Group type: EXPERIMENTAL
Intervention: Mizolastine 10 mg
Number of subjects: 141
Study: 7730247

Group type: EXPERIMENTAL
Intervention: Centrifugal pump (group 2)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Roller pump (group 1)
Number of subjects: 24
Study: 2077497

Group type: EXPERIMENTAL
Intervention: meperidine 0.50 mg/lb
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: meperidine 1.00 mg/lb
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: meperidine (highest dose)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: meperidine sedation
Number of subjects: 60

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 60
Study: 7443444

Group type: EXPERIMENTAL
Intervention: Probucol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31688449

Group type: EXPERIMENTAL
Intervention: Pooled antagonist group (haloperidol, flupentixol, olanzapine)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: First-generation antipsychotics (pooled)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Aripiprazole
Number of subjects: 69
Study: 28890299

Group type: EXPERIMENTAL
Intervention: Fluticasone/formoterol (125/6 mcg BD)
Number of subjects: 232

Group type: COMPARATOR
Intervention: Budesonide/formoterol (200/6 mcg BD)
Number of subjects: 232
Study: 27449067

Group type: EXPERIMENTAL
Intervention: Low-load resistance exercise (two sets of 15-20 repetition maximum)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Heavy-load resistance exercise (three sets of 5-8 repetition maximum)
Number of subjects: 20
Study: 24798817

Group type: EXPERIMENTAL
Intervention: Bridges to High School Program/Proyecto Puentes a la Secundaria
Number of subjects: 782
Study: 22510586

Group type: EXPERIMENTAL
Intervention: PMMA hard contact lens
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: RGP contact lens
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Soft silicone hydrogel contact lens
Number of subjects: 14

Group type: COMPARATOR
Intervention: No contact lens
Number of subjects: 14
Study: 20441811

Group type: EXPERIMENTAL
Intervention: Hands-on educational intervention including a demonstration and return demonstration of correct installation and use of a child passenger restraint
Number of subjects: 111

Group type: COMPARATOR
Intervention: Standardized education session on the safety and use of child passenger restraints (Control group)
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Hands-on educational intervention
Number of subjects: 111
Study: 17959530

Group type: EXPERIMENTAL
Intervention: Amikacin administration at 3-4 h postburn (group A)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Amikacin administration at 10 h postburn (group B)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Amikacin administration at 20 h postburn (group C)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Amikacin administration at 30 h postburn (group D)
Number of subjects: 20
Study: 16192549

Group type: EXPERIMENTAL
Intervention: Laryngeal Mask Airway (LMA)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Endotracheal Tube
Number of subjects: 69
Study: 11585103

Group type: EXPERIMENTAL
Intervention: Drug treatment guided by plasma levels of N-BNP
Number of subjects: 69

Group type: COMPARATOR
Intervention: Drug treatment based on clinical criteria
Number of subjects: 69
Study: 9686773

Group type: EXPERIMENTAL
Intervention: 2 mg efaroxan, given three times per day
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 8021526

Group type: EXPERIMENTAL
Intervention: Transesophageal echocardiography (TEE)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Magnetic resonance imaging (MRI)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Conventional transthoracic echocardiography (TTE)
Number of subjects: 35
Study: 2685934

Group type: EXPERIMENTAL
Intervention: Conservative management with limited surgical excision and radiotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Interstitial Ir‐192 boost dose to the tumor bed immediately following resection
Number of subjects: 0
Study: 30451147

Group type: EXPERIMENTAL
Intervention: Mediterranean lemonade (ML)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Green tea (GT)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Flavoured water (FW)
Number of subjects: 50
Study: 28655351

Group type: EXPERIMENTAL
Intervention: eSAGE
Number of subjects: 66

Group type: COMPARATOR
Intervention: SAGE
Number of subjects: 66
Study: 25956954

Group type: EXPERIMENTAL
Intervention: Intramuscular phloroglucinol (80 mg)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Oral misoprostol (400 mg)
Number of subjects: 120
Study: 23517244

Group type: EXPERIMENTAL
Intervention: Motivational interviewing (2 sessions)
Number of subjects: 135

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 135
Study: 21807831

Group type: EXPERIMENTAL
Intervention: Combination of COSP and CMHA services
Number of subjects: 139

Group type: COMPARATOR
Intervention: CMHA-only service
Number of subjects: 139
Study: 19523013

Group type: COMPARATOR
Intervention: Lecozotan 0.1, 0.25, 0.5, 1 and 5 mg q12h
Number of subjects: 65

Group type: COMPARATOR
Intervention: Lecozotan 0.5 mg and 5 mg q12h
Number of subjects: 65

Group type: COMPARATOR
Intervention: Single-dose lecozotan 2, 5 and 10 mg
Number of subjects: 65

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 65
Study: 16428552

Group type: EXPERIMENTAL
Intervention: 100 mouse units of BoNT/A
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pure saline (control)
Number of subjects: 0
Study: 15608803

Group type: EXPERIMENTAL
Intervention: Insulin resistance
Number of subjects: 589

Group type: EXPERIMENTAL
Intervention: Diabetes (both known and newly diagnosed)
Number of subjects: 589

Group type: EXPERIMENTAL
Intervention: Age-specific diabetes rates
Number of subjects: 589

Group type: EXPERIMENTAL
Intervention: Age-specific insulin resistance rates
Number of subjects: 589
Study: 11763111

Group type: EXPERIMENTAL
Intervention: 30 mg pyridostigmine bromide (PB) every 8 hours for 13 doses
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: 60 mg pyridostigmine bromide (PB) every 8 hours for 13 doses
Number of subjects: 67

Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 67
Study: 9750974

Group type: EXPERIMENTAL
Intervention: Individual cognitive‐behavior therapy (11 sessions)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Imipramine
Number of subjects: 93
Study: 7995616

Group type: EXPERIMENTAL
Intervention: Intranasal (D‐Ser6)‐gonadotrophin‐releasing hormone (GnRH) analogue (buserelin) administered at a mean dose of 25 micrograms/kg/day for a mean period of 14 months
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group (untreated patients)
Number of subjects: 22
Study: 2459641

Group type: EXPERIMENTAL
Intervention: Central argon laser panretinal photocoagulation (PRP)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Peripheral argon laser panretinal photocoagulation (PRP)
Number of subjects: 50
Study: 30921375

Group type: EXPERIMENTAL
Intervention: Simulated flight tasks for 2 hours
Number of subjects: 50

Group type: COMPARATOR
Intervention: Rest for 2 hours
Number of subjects: 50
Study: 28456026

Group type: EXPERIMENTAL
Intervention: Patients with schizophrenia treated in primary care
Number of subjects: 612
Study: 26714491

Group type: EXPERIMENTAL
Intervention: Supportive Parenting intervention (six additional home visits by a Youth Health Care nurse during the first 18 months after childbirth)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Care-as-usual (control group)
Number of subjects: 0
Study: 24159562

Group type: EXPERIMENTAL
Intervention: Amiodarone (median dose 300 mg)
Number of subjects: 2225

Group type: EXPERIMENTAL
Intervention: Baseline or new-onset abnormal thyroid function
Number of subjects: 2225

Group type: COMPARATOR
Intervention: Implantable cardioverter-defibrillator therapy
Number of subjects: 2225

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2225
Study: 21367849

Group type: EXPERIMENTAL
Intervention: Serum cystatin C (CysC)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Serum creatinine (Cr)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: CysC formula
Number of subjects: 160

Group type: COMPARATOR
Intervention: Cr formula
Number of subjects: 160
Study: 18481710

Group type: EXPERIMENTAL
Intervention: Xingnao Kaiqiao acupuncture (once each day, for 4 weeks) + routine treatment of western medicine
Number of subjects: 234

Group type: COMPARATOR
Intervention: Routine acupuncture + routine treatment of western medicine
Number of subjects: 234
Study: 17071427

Group type: EXPERIMENTAL
Intervention: Propess
Number of subjects: 100

Group type: COMPARATOR
Intervention: Prostin
Number of subjects: 100
Study: 11967729

Group type: EXPERIMENTAL
Intervention: Olmesartan medoxomil (10-20 mg once daily)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Olmesartan medoxomil (20-40 mg once daily)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Olmesartan medoxomil (5-20 mg once daily)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Olmesartan medoxomil
Number of subjects: 5
Study: 10101728

Group type: EXPERIMENTAL
Intervention: D-fenfluramine (D-FEN) 30 mg PO
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 7775610

Group type: EXPERIMENTAL
Intervention: Caffeine in patients with no liver disease
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Caffeine in patients with liver disease
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Caffeine biotransformation parameters (Cl and t1/2)
Number of subjects: 73
Study: 2264175

Group type: EXPERIMENTAL
Intervention: Prostaglandin E2 (PGE2) vaginal tablets
Number of subjects: 88

Group type: COMPARATOR
Intervention: Intravenous oxytocin
Number of subjects: 88
Study: 758705

Group type: EXPERIMENTAL
Intervention: Low molecular weight dextran
Number of subjects: 13

Group type: COMPARATOR
Intervention: Standard postoperative fluid therapy (Control)
Number of subjects: 13
Study: 6822321

Group type: EXPERIMENTAL
Intervention: Oleic acid
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Essential amino acids
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Glucose
Number of subjects: 6
Study: 31888626

Group type: EXPERIMENTAL
Intervention: Intravenous C1‐INH (50 IU/kg)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Intravenous C1‐INH
Number of subjects: 18
Study: 29458749

Group type: EXPERIMENTAL
Intervention: 500 mg ferric carboxymaltose (FCM)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 26007202

Group type: EXPERIMENTAL
Intervention: Music intervention combined with lifestyle modifications for 3 months
Number of subjects: 100

Group type: COMPARATOR
Intervention: Lifestyle modifications alone for 3 months
Number of subjects: 100
Study: 24563628

Group type: EXPERIMENTAL
Intervention: Scheduled home-based exercise intervention (strength training 3x/week and 30 minutes brisk walking/day)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Regular physical activity level (control group)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Scheduled home-based exercise intervention
Number of subjects: 67
Study: 22810740

Group type: EXPERIMENTAL
Intervention: Preventive therapy with pantogam at a mean dose of 1.8 g/daily
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Cessation therapy with pantogam at a mean dose of 1.2 g/daily
Number of subjects: 93

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 93
Study: 20514963

Group type: EXPERIMENTAL
Intervention: New method group (needle inserted into the skin at an angle of 20° and into the caudal space without redirection, n=35)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Conventional method group (caudal block performed with conventional needle insertion, n=40)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: New method group
Number of subjects: 75

Group type: COMPARATOR
Intervention: Conventional method group
Number of subjects: 75
Study: 17697863

Group type: EXPERIMENTAL
Intervention: Alpha-linolenic acid (ALA) supplementation via flaxseed oil capsules (increasing ALA to 5% of total energy intake) for 8 weeks.
Number of subjects: 57

Group type: COMPARATOR
Intervention: Control group instructed not to alter their habitual diet for 8 weeks.
Number of subjects: 57